38
Views
16
CrossRef citations to date
0
Altmetric
Perspective

Male circumcision for HIV prevention: developments from sub-Saharan Africa

, &
Pages 23-31 | Published online: 10 Jan 2014

References

  • Siegfried N, Muller M, Volmink J et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst. Rev. (3), CD003362 (2003).
  • Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med.2(11), e298 (2005).
  • Bailey RC, Moses S, Parker CB et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet369(9562), 643–656 (2007).
  • Gray RH, Kigozi G, Serwadda D et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet369(9562), 657–666 (2007).
  • Wawer MJ, Makumbi F, Kigozi G et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet374(9685), 229–237 (2009).
  • Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr.35(5), 435–445 (2004).
  • Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis.185(1), 45–52 (2002).
  • Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS20(1), 73–83 (2006).
  • Auvert B, Buve A, Ferry B et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS15(Suppl. 4), S15–S30 (2001).
  • Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999–2004. Sex Transm. Dis.34(7), 479–484 (2007).
  • Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm. Infect.82(2), 101–109; discussion 110 (2006).
  • Tobian AA, Serwadda D, Quinn TC et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N. Engl. J. Med.360(13), 1298–1309 (2009).
  • Sobngwi-Tambekou J, Taljaard D, Lissouba P et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J. Infect. Dis.199(7), 958–964 (2009).
  • Dickson NP, Ryding J, van Roode T et al. Male circumcision and serologically determined human papillomavirus infection in a birth cohort. Cancer Epidemiol. Biomarkers Prev.18(1), 177–183 (2009).
  • Nielson CM, Schiaffino MK, Dunne EF, Salemi JL, Giuliano AR. Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J. Infect. Dis.199(1), 7–13 (2009).
  • Madsen BS, van den Brule AJ, Jensen HL, Wohlfahrt J, Frisch M. Risk factors for squamous cell carcinoma of the penis – population-based case–control study in Denmark. Cancer Epidemiol. Biomarkers Prev.17(10), 2683–2691 (2008).
  • Hernandez BY, Wilkens LR, Zhu X et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J. Infect. Dis.197(6), 787–794 (2008).
  • Lajous M, Mueller N, Cruz-Valdez A et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol. Biomarkers Prev.14(7), 1710–1716 (2005).
  • Daling JR, Madeleine MM, Johnson LG et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int. J. Cancer116(4), 606–616 (2005).
  • Castellsague X, Bosch FX, Munoz N et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N. Engl. J. Med.346(15), 1105–1112 (2002).
  • Maden C, Sherman KJ, Beckmann AM et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J. Natl Cancer Inst.85(1), 19–24 (1993).
  • Kjaer SK, de Villiers EM, Dahl C et al. Case–control study of risk factors for cervical neoplasia in Denmark. I: role of the ‘male factor’ in women with one lifetime sexual partner. Int. J. Cancer48(1), 39–44 (1991).
  • Brinton LA, Reeves WC, Brenes MM et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int. J. Cancer44(2), 199–203 (1989).
  • Auvert B, Sobngwi-Tambekou J, Cutler E et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J. Infect. Dis.199(1), 14–19 (2009).
  • Mehta SD, Moses S, Agot K et al. Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya. J. Infect. Dis.200(3), 370–378 (2009).
  • Sobngwi-Tambekou J, Taljaard D, Nieuwoudt M, Lissouba P, Puren A, Auvert B. Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex. Transm. Infect.85(2), 116–120 (2009).
  • Castellsague X, Peeling RW, Franceschi S et al.Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men. Am. J. Epidemiol.162(9), 907–916 (2005).
  • Turner AN, Morrison CS, Padian NS et al. Male circumcision and women’s risk of incident chlamydial, gonococcal, and trichomonal infections. Sex. Transm. Dis.35(7), 689–695 (2008).
  • Gray RH, Kigozi G, Serwadda D et al. The effects of male circumcision on female partners’ genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am. J. Obstet. Gynecol.200(1), 42.e41–e47 (2009).
  • Gray RH, Kiwanuka N, Quinn TC et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS14(15), 2371–2381 (2000).
  • Hunter DJ, Maggwa BN, Mati JK, Tukei PM, Mbugua S. Sexual behavior, sexually transmitted diseases, male circumcision and risk of HIV infection among women in Nairobi, Kenya. AIDS8(1), 93–99 (1994).
  • Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS12(1), 75–84 (1998).
  • Kigozi G, Gray RH, Wawer MJ et al. The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med.5(6), e116 (2008).
  • Bailey RC, Egesah O, Rosenberg S. Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull. World Health Organ.86(9), 669–677 (2008).
  • Peltzer K, Nqeketo A, Petros G, Kanta X. Traditional circumcision during manhood initiation rituals in the Eastern Cape, South Africa: a pre-post intervention evaluation. BMC Public Health8, 64 (2008).
  • Mattson CL, Campbell RT, Bailey RC, Agot K, Ndinya-Achola JO, Moses S. Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS ONE3(6), e2443 (2008).
  • Agot KE, Kiarie JN, Nguyen HQ, Odhiambo JO, Onyango TM, Weiss NS. Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J. Acquir. Immune Defic. Syndr.44(1), 66–70 (2007).
  • Bailey RC, Neema S, Othieno R. Sexual behaviors and other HIV risk factors in circumcised and uncircumcised men in Uganda. J. Acquir. Immune Defic. Syndr.22(3), 294–301 (1999).
  • Seed J, Allen S, Mertens T et al. Male circumcision, sexually transmitted disease, and risk of HIV. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.8(1), 83–90 (1995).
  • Mehta SD, Gray RH, Auvert B et al. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS23(12), 1557–1564 (2009).
  • Kigozi G, Watya S, Polis CB et al. The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda. BJU Int.101(1), 65–70 (2008).
  • Kigozi G, Lukabwe I, Kagaayi J et al. Sexual satisfaction of women partners of circumcised men in a randomized trial of male circumcision in Rakai, Uganda. BJU Int. (2009) (Epub ahead of print).
  • WHO/UNAIDS. New data on male circumcision and HIV Prevention: policy and programme implications. WHO/Joint United Nations Programme on HIV/AIDS. Geneva, Switzerland (2007).
  • UNAIDS. Safe, voluntary, informed male circumcision and comprehensive HIV prevention programming: guidance for decision-makers on human rights, ethical and legal considerations. Joint United Nations Programme on HIV/AIDS. Geneva, Switzerland (2007).
  • WHO/UNAIDS. Country experiences in the scale-up of male circumcision in the eastern and southern Africa region: two years and counting. A sub-regional consultation. Windhoek, Namibia (2009).
  • UNAIDS/WHO. Progress in male circumcision scale-up. Country Implementation Update, July 2009. Joint United Nations Programme on HIV/AIDS. Geneva, Switzerland (2009).
  • Madhivanan P, Krupp K, Chandrasekaran V, Karat SC, Reingold AL, Klausner JD. Acceptability of male circumcision among mothers with male children in Mysore, India. AIDS22(8), 983–988 (2008).
  • Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav.11(3), 341–355 (2007).
  • de Bruyn G, Smith MD, Gray GE et al. Circumcision for prevention against HIV: marked seasonal variation in demand and potential public sector readiness in Soweto, South Africa. Implement. Sci.2, 2 (2007).
  • Martinson N, Selk F, McIntyre J, Gray G, Bridges J. Perceived benefits of male circumcision and client preferences for clinic design and marketing of male circumcision in Johannesburg, South Africa. Presented at: 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention. Cape Town, South Africa, 19–22 July 2009.
  • UNAIDS. Ethical considerations in biomedical HIV prevention trials. UNAIDS, Geneva, Switzerland (2007).
  • de Bruyn G, Martinson NA, Nkala BD et al. Uptake of male circumcision in an HIV vaccine efficacy trial. J. Acquir. Immune Defic. Syndr.51(1), 108–110 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.